OX-413

N/A

Report date: 2025/06/11 14:31:00
NME

Base Information

Drug NameOX-413
Drug Alias NameOX-413
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionPoly (ADP-Ribose) polymerase 1 stimulants
TargetsPoly (ADP-Ribose) polymerase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesValerio Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesValerio Therapeutics SA
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A